SFTPD and interstitial lung disease: The elevated serum levels of SP-D in patients with various forms of ILD could be attributed to an increase in SP-D production by regenerating alveolar type II pneumocytes and/or to the enhanced permeability of the air-blood barrier following the destruction of alveolar capillaries in the affected lung [13].